Previous Close | 5.20 |
Open | 5.55 |
Bid | 0.00 x N/A |
Ask | 5.65 x N/A |
Day's Range | 5.55 - 5.55 |
52 Week Range | 5.15 - 12.70 |
Volume | |
Avg. Volume | 0 |
Market Cap | 352.153M |
Beta (5Y Monthly) | 1.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SALT LAKE CITY, April 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2024 operating results on Thursday, May 9, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 800-267-6316 for
SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences: The Raymond James 45th Annual Institutional Investors Conference, being held in Orlando, including a fireside chat with Jason Alger, Chief Financial Officer, and Adam Brown, Senior Vice Pres
Today, Health Catalyst announced the winner of the 2024 Flywheel Award. The award recognizes healthcare organizations that have showcased outstanding results in measurable, impactful improvements. The announcement took place at the annual Healthcare Analytics Summit (HAS), the premier event showcasing data and analytics' critical role in tackling some of healthcare's most significant challenges.